Skip to main content
. Author manuscript; available in PMC: 2026 Oct 2.
Published in final edited form as: Transplant Cell Ther. 2026 Feb 2;32(6):670.e1–670.e14. doi: 10.1016/j.jtct.2026.01.031

Figure 2.

Figure 2.

WT versus NOD1×2−/− donor HSPCs transplanted in syngeneic hosts. (Panel A) Representative dot plots of donor (CD45.2+) cells in periphery after being injected 6 wk earlier into B6 (CD45.1+) recipient mice. (Panel B) Percentage WT versus NOD1×2−/− donor (CD45.2+) cells in syngeneic recipients (CD45.1+) at 6wk. Error bars are SD and represent n=4 mice/gp, data is representative of 2 identical experiments, ** p <.01.